A
Arnon Nagler
Researcher at Sheba Medical Center
Publications - 1435
Citations - 51740
Arnon Nagler is an academic researcher from Sheba Medical Center. The author has contributed to research in topics: Transplantation & Hematopoietic stem cell transplantation. The author has an hindex of 98, co-authored 1316 publications receiving 44298 citations. Previous affiliations of Arnon Nagler include French Institute of Health and Medical Research & University of Paris.
Papers
More filters
Journal ArticleDOI
Posttransplant cyclophosphamide vs antithymocyte globulin in HLA-mismatched unrelated donor transplantation.
Giorgia Battipaglia,Myriam Labopin,Nicolaus Kröger,Antonin Vitek,Boris V. Afanasyev,Inken Hilgendorf,Johannes Schetelig,Arnold Ganser,Didier Blaise,Maija Itälä-Remes,Jakob Passweg,Francesca Bonifazi,Jürgen Finke,Annalisa Ruggeri,Arnon Nagler,Mohamad Mohty +15 more
TL;DR: Use of PTCY is an effective anti GVHD prophylaxis also in the 9/10 MMUD transplant and may also provide better outcomes in long-term disease control, according to the haploidentical setting.
Journal ArticleDOI
Weighing the risks of G-CSF administration, leukopheresis, and standard marrow harvest: Ethical and safety considerations for normal pediatric hematopoietic cell donors
TL;DR: Granulocyte colony stimulating factor is used for collection of hematopoietic cells in most adult and a smaller but significant percentage of pediatric normal donor harvests.
Journal ArticleDOI
Deletion of chromosome band 13q14 as detected by fluorescence in situ hybridization is a prognostic factor in patients with multiple myeloma who are receiving allogeneic dose-reduced stem cell transplantation
Nicolaus Kröger,Georgia Schilling,Hermann Einsele,Peter Liebisch,Avichai Shimoni,Arnon Nagler,José A. Pérez-Simón,Jesús F. San Miguel,Michael G. Kiehl,Axel A. Fauser,Rainer Schwerdtfeger,Hannes Wandt,Herbert G. Sayer,Han Myint,Hans G. Klingemann,Tatjana Zabelina,Judith Dierlamm,Axel Hinke,Axel R. Zander +18 more
TL;DR: The impact of chromosome arm 13q deletion (13q-) as detected by fluorescence in situ hybridization (FISH) on outcome after dose-reduced allografting in patients with multiple myeloma was investigated in a retrospective multicenter study.
Journal ArticleDOI
Bacterial pneumonia in recipients of bone marrow transplantation : a five-year prospective study
Izidore S. Lossos,Raphael Breuer,Reuven Or,Nurith Strauss,Hanita Elishoov,Elizabeth Naparstek,Memet Aker,Arnon Nagler,Allon E. Moses,Mervyn Shapiro,Shimon Slavin,Dan Engelhard +11 more
TL;DR: VOD and GVHD are positively associated with post-BMT bacterial pneumonia, and its incidence, etiology, risk factors, and outcome are important considerations in its prevention and treatment.
Journal ArticleDOI
Prognostic factors for donor lymphocyte infusions following non-myeloablative allogeneic stem cell transplantation in multiple myeloma
N W C J van de Donk,N Kröger,Ute Hegenbart,Paolo Corradini,J F San Miguel,H. Goldschmidt,José Antonio Pérez-Simón,Mark Zijlmans,Reinier Raymakers,Vittorio Montefusco,Francis Ayuk,M. H. J. Van Oers,Arnon Nagler,Leo F. Verdonck,H M Lokhorst +14 more
TL;DR: Donor lymphocyte infusion following non-myeloablative Allo-SCT is a valuable strategy for relapsed or persistent disease and there was a trend towards significance for time between transplantation and DLI, and response.